Cargando…

Assessment of the efficiency and safety of anti-coagulation therapy in patients with liver cirrhosis and atrial fibrillation

AIM OF THE STUDY: Currently, there are insufficient scientific data regarding the efficacy and safety of direct oral anticoagulants (DOACs) compared to warfarin in patients with both liver cirrhosis (LC) and atrial fibrillation (AF). The aim of the study was to analyze the frequency and risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baylo, Alina, Cherniavskyi, Volodymyr, Reshotko, Dmytro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544060/ https://www.ncbi.nlm.nih.gov/pubmed/37790690 http://dx.doi.org/10.5114/ceh.2023.130605

Ejemplares similares

Update on anti-coagulation in atrial fibrillation
por: Kreuzer, J.
Publicado: (2011)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

Calciphylaxis in the Setting of Hemodialysis, Liver Cirrhosis, and Warfarin Therapy for Atrial Fibrillation: An Argument for Alternative Anti-Embolic Therapy
por: Medepalli, Vidya M, et al.
Publicado: (2020)

Liver cirrhosis prevents atrial fibrillation: A reality or just an illusion?
por: Zamirian, Mahmood, et al.
Publicado: (2012)

Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?
por: Gîrleanu, Irina, et al.
Publicado: (2023)

Antiplatelet and Anti-Coagulation Therapy for Left-Sided Catheter Ablations: What Is beyond Atrial Fibrillation?
por: Nesti, Martina, et al.
Publicado: (2023)

Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis
por: van Til, Janine, et al.
Publicado: (2020)

Paroxysmal Atrial Fibrillation: Insight Into the Intimate Mechanisms of Coagulation
por: Negreva, Mariya, et al.
Publicado: (2020)

Coagulation Proteins Influencing Global Coagulation Assays in Cirrhosis: Hypercoagulability in Cirrhosis Assessed by Thrombomodulin-Induced Thrombin Generation Assay
por: Youngwon, Nam, et al.
Publicado: (2013)

The effects of magnesium on the course of atrial fibrillation and coagulation in patients with atrial fibrillation undergoing mitral valve annuloplasty
por: Kang, Woon-Seok, et al.
Publicado: (2011)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population‐based cohort study
por: B. Riahi, Emil, et al.
Publicado: (2022)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

The association of coagulation and atrial fibrillation: a systematic review and meta-analysis
por: Tilly, Martijn J, et al.
Publicado: (2022)

Inflammation and Coagulation are Two Interconnected Pathophysiological Pathways in Atrial Fibrillation Pathogenesis
por: Hazarapetyan, Lusine, et al.
Publicado: (2023)

Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2020)

Early Coagulation Disorder Is Associated With an Increased Risk of Atrial Fibrillation in Septic Patients
por: Long, Yunxiang, et al.
Publicado: (2021)

Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis
por: Luo, Yanting, et al.
Publicado: (2021)

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation
por: Li, Jiang, et al.
Publicado: (2021)

A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma.
por: Park, C. J., et al.
Publicado: (1991)

Disseminated intravascular coagulation score predicts mortality in critically ill patients with liver cirrhosis
por: Drolz, A, et al.
Publicado: (2015)

Changes in fibrinolytic activity and coagulation factors after epicardial left atrial appendage closure in patients with atrial fibrillation
por: Litwinowicz, Radoslaw, et al.
Publicado: (2022)

Direct Effects of Activation and Inhibition of the Coagulation System on the Atrial Fibrillation Substrate: Is Anticoagulation Antiarrhythmic?
por: Nattel, Stanley
Publicado: (2016)

Predictive factors associated with bleeding in atrial fibrillation patients treated with anti-coagulant drugs using a large claims database
por: Momo, Kenji, et al.
Publicado: (2020)

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
por: Kuo, Ling, et al.
Publicado: (2017)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications
por: Tischendorf, Michael, et al.
Publicado: (2016)

Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
por: Silva, Vanessa M., et al.
Publicado: (2019)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Gallagher, Celine, et al.
Publicado: (2019)

Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites
por: Thaler, Johannes, et al.
Publicado: (2021)

Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke
por: Ellis, Deandrea, et al.
Publicado: (2018)

Lupus Antibody Mimicking Reduced Plasmatic Coagulation in a Patient With Atrial Fibrillation and Ischemic Stroke
por: Huseynov, Aydin, et al.
Publicado: (2020)

Coagulation Biomarkers for Predicting Clinical Outcomes Among Patients With Atrial Fibrillation: Piecing Together the Biomarkers
por: Choi, Eue-Keun, et al.
Publicado: (2023)

Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation: ANAFIE Subcohort Study
por: Koretsune, Yukihiro, et al.
Publicado: (2023)

Late onset cardiac cirrhosis and portal hypertensive ascites after atrial fibrillation ablation
por: Fong, Tse-Ling, et al.
Publicado: (2018)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
por: Mu, Li-ya, et al.
Publicado: (2021)

Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis
por: Alhassan, Hassan A., et al.
Publicado: (2023)

Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation
por: Sun, Xuerong, et al.
Publicado: (2021)

Safety and Efficacy of Apixaban in the Treatment of Atrial Fibrillation
por: Martin, Andrew, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_94o7d4cr5mpn5glbqrgorjopvr